Cargando…
A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
BACKGROUND: Recent reports indicate that the isoxazoline compounds have the potential to provide safe and effective treatment of canine generalized demodicosis, a condition that has been traditionally difficult to cure. Controlled field studies are needed to confirm this potential. A study was there...
Autores principales: | Petersen, Ivo, Chiummo, Rafael, Zschiesche, Eva, Karas-Tecza, Joanna, Rapti, Dhimiter, Roepke, Rainer, Thomas, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291464/ https://www.ncbi.nlm.nih.gov/pubmed/32527282 http://dx.doi.org/10.1186/s13071-020-04159-2 |
Ejemplares similares
-
Field efficacy of fluralaner (Bravecto(®) chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs
por: Chiummo, Rafael, et al.
Publicado: (2023) -
Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020) -
Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017) -
Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014) -
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)